Study | N | Population | Perforation rate |
---|---|---|---|
Sebastian et al. (5) | 1198 | Unselected patients | 3.76 |
Bielawska et al. (12) | 8 | Chemotherapy | 0 |
Karoui et al. (13) | 19 | Chemotherapy | 11 |
Fernandez-Esparrach et al. (14) | 26 | Chemotherapy | 8 |
Karoui et al. (15) | 22 | Chemotherapy | 9 |
van Hooft et al. (20) | 6 | Chemotherapy | 66 |
Cennamo et al. (21) | 2 | Chemotherapy + bevacizumab | 100 |
Small et al. (22) | 23 | Chemotherapy + bevacizumab | 17.4 |
Manes et al. (23) | 8 | Chemotherapy + bevacizumab | 50 |
SEMS = self-expanding metal stent.